Vanguard Group
NMTC icon

Vanguard Group’s NeuroOne Medical Technologies NMTC Stock Holding History

Vanguard Group’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.2M Hold
263,040
– – ﹤0.01% 3724
2025
Q3 		$1.4M Buy
263,040
+62,607
+31% +$306K ﹤0.01% 3682
2025
Q2 		$815K Buy
200,433
+15,318
+8% +$56.6K ﹤0.01% 3801
2025
Q1 		$944K Buy
185,115
+31,860
+21% +$202K ﹤0.01% 3727
2024
Q4 		$760K Hold
153,255
– – ﹤0.01% 3836
2024
Q3 		$910K Hold
153,255
– – ﹤0.01% 3806
2024
Q2 		$736K Buy
153,255
+35
+0% +$220 ﹤0.01% 3892
2024
Q1 		$1.1M Buy
153,220
+282
+0.2% +$2.13K ﹤0.01% 3780
2023
Q4 		$1.45M Buy
152,938
+79,691
+109% +$587K ﹤0.01% 3714
2023
Q3 		$391K Sell
73,247
-129
-0.2% -$864 ﹤0.01% 4123
2023
Q2 		$528K Sell
73,376
-768
-1% -$6.22K ﹤0.01% 4104
2023
Q1 		$716K Buy
74,144
+59,200
+396% +$548K ﹤0.01% 4012
2022
Q4 		$108K Buy
14,944
+1,124
+8% +$10.1K ﹤0.01% 4382
2022
Q3 		$141K Sell
13,820
-26,079
-65% -$248K ﹤0.01% 4462
2022
Q2 		$197K Hold
39,899
– – ﹤0.01% 4470
2022
Q1 		$264K Buy
39,899
+3,694
+10% +$44.8K ﹤0.01% 4495
2021
Q4 		$421K Buy
+36,205
New +$586K ﹤0.01% 4456

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Vanguard Group's NMTC Position: Q4 2025 in Review

Vanguard Group held its NeuroOne Medical Technologies (NMTC) position steady in Q4 2025 at 263,040 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3724.

Vanguard Group first reported a position in NMTC in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.45M in Q4 2023. 37 funds tracked by Wall St. Rank hold NMTC as of Q4 2025.

  • Vanguard Group held 263,040 shares of NeuroOne Medical Technologies worth $1.2M as of Q4 2025.
  • Vanguard Group left its NeuroOne Medical Technologies share count unchanged in Q4 2025.
  • NeuroOne Medical Technologies made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3724 holding.
  • Vanguard Group first reported a position in NeuroOne Medical Technologies in Q4 2021 and has held it in 17 quarters since.
  • Vanguard Group's NeuroOne Medical Technologies position peaked at $1.45M in Q4 2023.
  • 37 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.